Jennifer Tousignant, Chief Legal Officer at Viridian Therapeutics, Inc. ($VRDN), made one open market sale of company shares in the last year, totaling $70,796. Her most recent sale occurred on December 31, 2025. Among 11,678 insiders with sales, her activity ranks 10,016th by amount, well below the average of $8.6 million across 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | F | Common Stock | 1675 | $30.19 | 3,494.0000 | 95,442,008 | 32.40% | 0.00% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | M | Restricted Stock Units | 5169 | $0.00 | 15,510.0000 | 95,442,008 | 25.00% | 0.01% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | M | Common Stock | 5169 | $0.00 | 5,169.0000 | 95,442,008 | 9999.99% | 0.01% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | F | Common Stock | 1724 | $29.32 | 3,445.0000 | 95,442,008 | 33.35% | 0.00% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 119300 | $0.00 | 119,300.0000 | 95,442,008 | 9999.99% | 0.13% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | A | Restricted Stock Units | 23850 | $0.00 | 23,850.0000 | 95,442,008 | 9999.99% | 0.02% |
| Dec. 31, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | S | Common Stock | 2272 | $31.16 | 0.0000 | 95,442,008 | 100.00% | 0.00% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | A | Restricted Stock Units | 20679 | $0.00 | 20,679.0000 | 81,484,950 | 9999.99% | 0.03% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 124072 | $0.00 | 124,072.0000 | 81,484,950 | 9999.99% | 0.15% |
| Feb. 12, 2024 | Viridian Therapeutics, Inc.\DE | $VRDN | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 290000 | $0.00 | 290,000.0000 | 0 | 9999.99% | 0.00% |